Best Telehealth Clinics in Mississippi (2026)

Mississippi's telehealth framework is governed by MS Code § 83-9-351 (telehealth coverage and definitions) and § 83-9-353 (store-and-forward and remote patient monitoring). The Board of Medical Licensure rules, Part 2635 Chapter 5, provide additional prescribing guidance. Mississippi made its private payer telehealth coverage law permanent by removing the original sunset date.

Mississippi has a critical restriction: telehealth shall not be used for the management of chronic pain with controlled substance prescription drugs. This is a Board of Medical Licensure rule, not just a statutory provision, and it applies broadly to ongoing controlled substance prescribing for pain indications. Standard TRT is not classified as chronic pain treatment, but the rule creates a gray area for telehealth platforms prescribing controlled substances regularly.

Telemedicine in Mississippi requires real-time audio-video consultation. Audio-only telephone, email, and fax do not qualify as telemedicine under state law. Initial consultations involving controlled substances require video.

Mississippi is an active IMLC member with SPL status. Out-of-state physicians can obtain expedited Mississippi licensure through the compact.

Mississippi has reduced NP practice authority. APRNs must maintain a career-long collaborative agreement with a physician. Physician supervision is required for Schedule II controlled substance prescribing. This limits NP-staffed telehealth platforms operating in the state.

Mississippi Medicaid does not cover GLP-1 receptor agonists for obesity. The legislature passed SB 2867 to expand coverage, but the governor vetoed it on fiscal grounds. Coverage remains limited to diabetes indications.

Mississippi's combination of the chronic pain controlled substance telehealth ban, reduced NP practice authority, and the Board's broad interpretation of telemedicine restrictions makes it a challenging state for telehealth controlled substance prescribing. Enhance MD excludes Mississippi from its service area.

Mississippi has 3.0 million residents. Provider availability for controlled substance telehealth is below average due to the chronic pain CS telehealth ban and reduced NP practice authority. Enhance MD excludes Mississippi.

All-50-state providers like Maximus ($100/mo) and Hone Health ($25/mo) serve Mississippi. TRT Nation ($99/mo, 45 states) includes MS. BraverX ($129/mo), PeterMD ($99/mo), and DudeMeds ($77/mo) list "Most US states" — verify Mississippi coverage directly. TRT is not chronic pain treatment, so the telehealth CS ban should not directly apply, but the regulatory environment creates caution among providers.

GLP-1 availability is unrestricted since GLP-1s are not controlled substances. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, and Mochi Health serve Mississippi. No Medicaid GLP-1 obesity coverage after the governor's veto of SB 2867.

HRT, hair loss, and ED providers with national coverage generally serve Mississippi for non-controlled medications. Midi Health accepts insurance.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Mississippi Medicaid does not cover GLP-1s for obesity despite legislative effort (SB 2867 vetoed). Patients pay the full out-of-pocket cost.

Mississippi does not tax prescription medications. The state sales tax is 7% (among the highest nationally) but Rx drugs are exempt. Mississippi has a flat income tax of 4.4% (reduced from 4.7% in 2025).

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

Mississippi has one of the lowest costs of living in the country. Telehealth pricing is national but represents a larger share of disposable income in lower-income areas.

TRT (testosterone replacement therapy)

Mississippi's chronic pain controlled substance telehealth ban (Board Part 2635 Chapter 5) does not directly apply to TRT, which is not a chronic pain treatment. However, the broad language creates compliance caution among telehealth platforms. Enhance MD excludes MS. Real-time audio-video required. Reduced NP practice authority limits NP-staffed platforms. Both compounded and FDA-approved testosterone are available.

GLP-1 weight loss

No state-specific GLP-1 restrictions. Federal FDA compounding rules apply. Mississippi Medicaid does not cover GLP-1s for obesity (SB 2867 vetoed). Commercial insurance coverage varies.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Mississippi. No additional state restrictions apply for non-controlled HRT medications.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Mississippi. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Mississippi. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules. The chronic pain CS telehealth ban may be relevant for controlled peptides used in pain-adjacent contexts. Non-controlled peptides are unaffected.